ENDRA Life Sciences (NDRA) Receivables (2017 - 2018)

ENDRA Life Sciences (NDRA) posted quarterly Receivables of $12275.0 for Q3 2018, up 4.29% sequentially from $11770.0 in Q2 2018.

ENDRA Life Sciences (NDRA) Receivables (2017 - 2018) Analysis & Trends

ENDRA Life Sciences has disclosed Receivables across 2 years of filings, most recently posting $12275.0 for Q3 2018.

In Q3 2018, Receivables changed N/A year-over-year to $12275.0; the TTM figure through Sep 2018 stood at $12275.0 (changed N/A YoY), while the FY2017 annual figure was $6850.0, changed N/A from the prior year.
Receivables improved to $12275.0 in Q3 2018, from $11770.0 in the prior quarter.
Over the last five years, Receivables for NDRA reached as high as $12275.0 in Q3 2018 and fell as low as $6850.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	1.75 Bn
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	10.89 Bn
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	3.82 Bn
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	922.24 Mn
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	417.60 Mn
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	1.82 Bn
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	5.16 Bn
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	761.00 Mn
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	751.11 Mn
10	ENDRA Life Sciences	5.95 Mn	5.59 Mn	-	-

Download Data